Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2010-10-05
2011-10-18
Whisenant, Ethan C (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S023100, C536S024300
Reexamination Certificate
active
08039213
ABSTRACT:
Methods are provided for accurately predicting efficacy of chemotherapeutic agents. Methods of the invention increase the positive predictive value of chemosensitivity assays by assessing both the ability of a chemotherapeutic to destroy cells and the genetic propensity of those cells for resistance. Results obtained using methods of the invention provide insight into the in vivo effectiveness of a therapeutic, and lead to more effective chemotherapeutic treatment.
REFERENCES:
patent: 4423145 (1983-12-01), Stampfer et al.
patent: 4559299 (1985-12-01), Rotman
patent: 4668618 (1987-05-01), Thornthwaite
patent: 4816395 (1989-03-01), Hancock et al.
patent: 4937187 (1990-06-01), Rotman
patent: 4996145 (1991-02-01), Weisenthal
patent: 5242806 (1993-09-01), Yen-Maguire et al.
patent: 5270172 (1993-12-01), Morgan
patent: 5403574 (1995-04-01), Piwnica-Worms
patent: 5443950 (1995-08-01), Naughton et al.
patent: 5607918 (1997-03-01), Eriksson et al.
patent: 5705270 (1998-01-01), Soon-Shiong et al.
patent: 5728541 (1998-03-01), Kornblith
patent: 5789158 (1998-08-01), Knowles et al.
patent: 5874218 (1999-02-01), Drolet et al.
patent: 5888765 (1999-03-01), Patterson et al.
patent: 5942385 (1999-08-01), Hirth
patent: 5972639 (1999-10-01), Parandoosh
patent: 6008007 (1999-12-01), Fruehauf et al.
patent: 6020473 (2000-02-01), Keyt et al.
patent: 6111092 (2000-08-01), Williamson
patent: 6261795 (2001-07-01), Fruehauf et al.
patent: 6303324 (2001-10-01), Fruehauf
patent: 6335170 (2002-01-01), Orntoft
patent: 6416967 (2002-07-01), Kornblith
patent: 6511806 (2003-01-01), Fruehauf et al.
patent: 6664062 (2003-12-01), Stanton, Jr.
patent: 6887680 (2005-05-01), Kornblith
patent: 6900027 (2005-05-01), Kornblith
patent: 6933129 (2005-08-01), Kornblith
patent: 7112415 (2006-09-01), Kornblith
patent: 7314731 (2008-01-01), Kornblith
patent: 7563593 (2009-07-01), Kornblith
patent: 7829288 (2010-11-01), Kornblith et al.
patent: 2002/0168679 (2002-11-01), Naus et al.
patent: 2002/0192638 (2002-12-01), Kornblith
patent: 2003/0096290 (2003-05-01), Fruehauf et al.
patent: 2004/0023375 (2004-02-01), Kornblith et al.
patent: 2004/0072722 (2004-04-01), Kornblith et al.
patent: 2004/0086888 (2004-05-01), Kornblith et al.
patent: 2007/0059821 (2007-03-01), Kornblith et al.
patent: 2008/0085519 (2008-04-01), Gabrin et al.
patent: 0911389 (1999-04-01), None
patent: WO 96/10742 (1996-04-01), None
patent: WO 98/02038 (1998-01-01), None
patent: WO 98/02038 (1998-01-01), None
patent: WO 00/75287 (2000-12-01), None
patent: WO 01/65994 (2001-09-01), None
patent: WO 01/79540 (2001-10-01), None
patent: WO 02/33117 (2002-04-01), None
patent: WO 2004/015065 (2004-02-01), None
patent: WO 2004/035833 (2004-04-01), None
patent: WO 2004/035833 (2004-04-01), None
Abstract for JP 2003-199585, Database WPI Week 200377, Jul. 15, 2003, XP002450791.
Supplementary European Search Report based on International Application No. PCT/US2003/032285, (Oct. 8, 2007).
PL Kornblith et al., “Response variability of human brain tumors to AZQ in tissue cultures”. Journal of Neuro-Oncology, 1986, pp. 49-54, vol. 4, Martinus Nijhoff Publishers, Boston.
RS Weinstein et al., “Ultrastructure of a cloned astrocytoma in tissue cultures,” Cancer, 1971, pp. 1174-1181, vol. 27.
PMoL Black et al., “Ultrastructural and electrophysiological features of maningloma whoris in tissue culture,” Acta Neuropathol (Ber). 1979, vol. 46, pp. 33-38.
RM Scott et al., “Invasiveness in tissue culture: A technique for study of gliomas,” Surg Forum, 1978, pp. 531-533, vol. 29.
T. Liszczak et al., “Morphological, biochemical, ultrastructural, tissue culture and clinical observations of typical and aggressive craniopharyngiomas,” Acta Neuropathol (Berl), 1978, pp. 191-203, vol. 43.
PL Kornblith et al., “Growth-inhibitory effects of diphenythydantoin on human brain tumor cells in culture,” Neurosurgery, 1978, pp. 122-127, vol. 2.
RR Weichselbaum et al., “Characterization and radiobiologic parameters of medulloblastoma in vitro,” Cancer, 1977, pp. 1087-1096, vol. 40.
RL Martuza et al., “Characteristics of human optic gilomas in tissue culture,” J. Neurosurg, 1977, pp. 78-84, vol. 46.
MA Oberc-Greenwood, et al., “Ultrastructural features of the lymphocyte-stimulated halos produced by human glloma-derived cells in vitro,” Journal of Neuro-Oncology, 1986, pp. 387-396, vol. 3.
BH Smith et al., “Membrane and cytoplasmic changes in 1,3-bis (2-chloroathy 1)-1-nitrosource (8CND)-sensitive and resistant human malignant glloma-derived cell lines” Journal of Neuro-Oncology, 1983, pp. 237-248, vol. 1.
GA Curt et al., “Phase II and pharmacokinetic study of aziridinyl-benzoquinoria (2,5-diaziridinyl-3,6-bis(carboethoxyaminc)-1,4 benzoquinone, diaziquone, NSC 182986) in high grade gllomas,” Cancer Research, 1983, pp. 6102-6105, vol. 43, Issue 12 pt. 1.
N Shitara et al., “Flowcytomeric and cytogenetic analysis of human cultured cell lines derived from high- and low-grades astrocytomas,” Acta Neuropathol (Berl), 1983, pp. 40-46, vol. 60.
MK Gumerlock et al., “Chemical differeniiation of cultured human giloma cells: Morphologic and Immunologic effects,” Surgical Forum, 1981, pp. 475-477, vol. XXXII.
PL Kornblith et al., “Growth-inhibitory effect of diphenythydantoin on murine astrocytornas,” Neurosurgery, 1979, pp. 259-263, vol. 5.
MC Trachtenberg et al., “Biophysical properties of cultured human gliaf cells,” Brain Research, 1972, pp. 279-298, vol. 38.
J. Lightbody et al., “Biochemically differentiated clonal human glial cells in tissue culture,” J. Neurobiology, 1970, pp. 411-417, vol. 1, No. 4.
PMcL Black et al., “Biophysical properties of human astrocytic brain tumor cells in cell nature,” Journal of Cellular Physiology, 1980, pp. 565-570, vol. 105.
TM Liszczak et al., “Ultrastructure of human endometrial epitheiium in monolayer culture with and without steroid hormones,” In Vitro, 1977, pp. 344-356, vol. 13, No. 6.
TM Liszozak et al., “Procedure for the embedmeril and ultrastructural visualization of cells cultured on plastic microfest plates,” Journal of Immunological Methods, 1977, pp. 131-134, vol. 15.
RM Stewart et al., “Glutamate accumulation by human gliomas and meningiomas in tissue culture” Brain Research, 1976, pp. 441-452, vol. 118.
PL Kornblith et al., “The future of therapy for globlastorna,” Surg Neurol, 1993, pp. 536-543, vol. 39.
PL Kornblith, “Management of mailgnant gliomas,” Neurosurgery Quarterly, 1991, pp. 97-110, vol. 1, Issue 2.
PL Kornblith et al., “Chemotherapy for malignant gllomas,” Journal of Neurosurgery, 1986, pp. 1-17, vol. 68, Issue 1.
PE McKeever et al., “Products of cells cultured from gllomas: VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomas,” American Journal of Pathology, 1987. pp. 356-372, vol. 127, Issue 2.
PmCL Black et al., “Immunological, biological, ultrastructural, and electrophysiological characteristics of a human glioblastoma-derived cell culture line,” J. Neurosurg, 1982, pp. 62-72, vol. 56.
PL Kornblith, “The role of cylotoxic chemotherapy in the treatment of malignant brain tumors,” Surg Neurol, 1995, pp. 551-552, vol. 44.
WC Welch et al., “Morphologic immunologic, biochemical and cytogenetic characteristics of the human glioblastoma-derived cell line, SNB-19,” Journal of the Society for In Vitro Biology, 1995, pp. 610-616, vol. 31.
E Sariban et al., “DNA crosslinking response of human malignant glioma cell strains to chloroethytrillrosoureas. cisplatin and diaziquone.” Cancer Research, 1987, pp. 3988-3994, vol. 47, Issue 15.
Alley, M., “Morphometric and Colorímetríc Analyses of Human Tumor Cell Line Growth and Drug Sensitivity in Soft Agar Culture,”
Kornblith Paul L.
McDonald Sean
Cooley LLP
Precision Therapeutics, Inc.
Whisenant Ethan C
LandOfFree
Methods for assessing efficacy of chemotherapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for assessing efficacy of chemotherapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for assessing efficacy of chemotherapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4255729